Education
About Us
Working with TipRanks
Follow Us
GRI Bio (GRI)
NASDAQ:GRI
Total Valuation
GRI Bio has a market cap or net worth of $1.10M. The enterprise value is -$5.33M.
Market Cap$1.10M
Enterprise Value-$5.33M
Share Statistics
GRI Bio has 727.36K shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding727.36K
Owened by Insiders6.41%
Owened by Instutions0.34%
Financial Efficiency
GRI Bio’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee$1,798,000
Profits Per Employee-$2,754,666.667
Employee Count3
Asset Turnover7.36
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GRI Bio is -19.44. GRI Bio’s PEG ratio is -0.08.
PE Ratio-19.44
PS Ratio11.65
PB Ratio978.70
Price to Fair Value978.70
Price to FCF-28.17
Price to Operating Cash Flow-27.73
PEG Ratio-0.08
Income Statement
In the last 12 months, GRI Bio had revenue of $5.39M and earned -$8.26M in profits. Earnings per share was -$9.28.
Revenue$5.39M
Gross Profit$5.38M
Operating Income-$8.31M
Pretax Income-$8.26M
Net Income-$8.26M
EBITDA-8.26M
Earnings Per Share (EPS)-9.28
Cash Flow
In the last 12 months, operating cash flow was -$12.17M and capital expenditures $0.00, giving a free cash flow of -$12.17M billion.
Operating Cash Flow-$12.17M
Free Cash Flow-$12.17M
Free Cash Flow per Share-$16.73
Dividends & Yields
GRI Bio pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change-98.75%
50-Day Moving Average7.32
200-Day Moving Average12.90
Relative Strength Index (RSI)22.37
Average Volume (3m)564.99K
Important Dates
GRI Bio upcoming earnings date is Aug 14, 2024, Before Open.
Last Earnings DateMay 13, 2024
Next Earnings DateAug 14, 2024
Ex-Dividend Date―
Financial Position
GRI Bio as a current ratio of 1.09, with Debt / Equity ratio of 0.05
Current Ratio1.09
Quick Ratio1.09
Debt to Market Cap0.00
Net Debt to EBITDA―
Interest Coverage Ratio-5.47
Taxes
In the past 12 months, GRI Bio has paid $1.57M in taxes.
Income Tax$1.57M
Effective Tax Rate-21.21%
Enterprise Valuation
GRI Bio EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
GRI Bio has $4.75M in cash and marketable securities with $131.00K in debt, giving a net cash position of -$4.62M billion.
Cash & Marketable Securities$4.75M
Total Debt$131.00K
Net Cash-$4.62M
Net Cash Per Share-$6.34
Tangible Book Value Per Share$0.56
Margins
Gross margin is 99.74%, with operating margin of -52.31%, and net profit margin of -59.89%.
Gross Margin99.74%
Operating Margin-52.31%
Pretax Margin-59.89%
Net Profit Margin-59.89%
EBITDA Margin-50.07%
EBIT Margin-50.33%
Analyst Forecast
The average price target for GRI Bio is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside562.25%
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast98.55%